Target Validation in Drug Discovery
Latest Publications

TOTAL DOCUMENTS

17

(FIVE YEARS 0)

H-INDEX

2

(FIVE YEARS 0)

Published By Elsevier

9780123693938

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

ANTI-CCL-2/MCP-1: DIRECTED BIOLOGICALS FOR INFLAMMATORY AND MALIGNANT DISEASES

Target Validation in Drug Discovery ◽

10.1016/b978-012369393-8/50007-9 ◽

2007 ◽

pp. 103-119 ◽

Cited By ~ 1

Author(s):

ANUK DAS ◽

LI YAN

Keyword(s):

Malignant Diseases

Download Full-text

PROGRESS IN ACHIEVING PROOF OF CONCEPT FOR p38 KINASE INHIBITORS

Target Validation in Drug Discovery ◽

10.1016/b978-012369393-8/50011-0 ◽

2007 ◽

pp. 179-198

Author(s):

JERRY L ADAMS ◽

JOHN C. LEE

Keyword(s):

Kinase Inhibitors ◽

Proof Of Concept ◽

P38 Kinase

Download Full-text

IKK-2/NF-κB-DEPENDENT TRANSCRIPTION

Target Validation in Drug Discovery ◽

10.1016/b978-012369393-8/50012-2 ◽

2007 ◽

pp. 199-221

Author(s):

F. CHRISTOPHER ZUSI ◽

WILLIAM J. PITTS ◽

JAMES R. BURKE

Download Full-text

VALIDATION OF TNF AS A DRUG TARGET IN INFLAMMATORY BOWEL DISEASE

Target Validation in Drug Discovery ◽

10.1016/b978-012369393-8/50006-7 ◽

2007 ◽

pp. 83-102

Author(s):

MICHAEL J. ELLIOTT

Keyword(s):

Inflammatory Bowel Disease ◽

Bowel Disease ◽

Drug Target ◽

Inflammatory Bowel

Download Full-text

TNF SIGNALING PATHWAY INHIBITORS FOR INFLAMMATION-CCR2 ANTAGONISTS

Target Validation in Drug Discovery ◽

10.1016/b978-012369393-8/50013-4 ◽

2007 ◽

pp. 223-240

Author(s):

KRIS VADDI

Keyword(s):

Signaling Pathway

Download Full-text

ORALLY BIOAVAILABLE GLYCOPROTEIN IIB/IIIA ANTAGONISTS: A NEGATIVE CASE STUDY

Target Validation in Drug Discovery ◽

10.1016/b978-012369393-8/50015-8 ◽

2007 ◽

pp. 255-268

Author(s):

DIETMAR A. SEIFFERT ◽

JEFFREY T. BILLHEIMER

Keyword(s):

Negative Case ◽

Orally Bioavailable

Download Full-text

TARGET VALIDATION IN CHEMOGENOMICS

Target Validation in Drug Discovery ◽

10.1016/b978-012369393-8/50003-1 ◽

2007 ◽

pp. 27-39

Author(s):

TOM Y-H. WU ◽

SHENG DING

Keyword(s):

Target Validation

Download Full-text

CONTRIBUTORS

Target Validation in Drug Discovery ◽

10.1016/b978-012369393-8/50001-8 ◽

2007 ◽

pp. xi-xii

Author(s):

Jerry L. Adams ◽

Shannon E. Beard ◽

Jacqueline Benson ◽

Jeffrey T. Billheimer ◽

James R. Burke ◽

...

Download Full-text

CETUXIMAB (ERBITUX®), AN ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY FOR THE TREATMENT OF METASTATIC COLORECTAL CANCER

Target Validation in Drug Discovery ◽

10.1016/b978-012369393-8/50004-3 ◽

2007 ◽

pp. 43-67

Author(s):

ZHENPING ZHU

Keyword(s):

Colorectal Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Metastatic Colorectal Cancer ◽

Growth Factor Receptor ◽

Receptor Antibody ◽

Epidermal Growth

Download Full-text

THE GPIIB/IIIA ANTAGONIST ABCIXIMAB FOR ACUTE PERCUTANEOUS CORONARY INTERVENTION

Target Validation in Drug Discovery ◽

10.1016/b978-012369393-8/50009-2 ◽

2007 ◽

pp. 135-152 ◽

Cited By ~ 1

Author(s):

ROBERT E. JORDAN

Keyword(s):

Percutaneous Coronary Intervention ◽

Coronary Intervention ◽

Percutaneous Coronary

Download Full-text